Cancer Nanotheranostics
After a quarter of century of express technological advances, research has publicized the convolution of cancer, a disease confidentially related to the dynamic transformation of the genome. It is here that Nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. Nanotechnology offers numerous tools to diagnose and treat cancer, such as new imaging agents, multifunctional devices capable of overcome biological barriers to deliver therapeutic agents directly to cells and tissues involved in cancer growth and metastasis, and devices capable of predicting molecular changes to prevent action against precancerous cells. Nanomaterials-based delivery systems in Theranostics (Diagnostics & Therapy) provide better penetration of therapeutic and diagnostic substances within the body at a reduced risk in comparison to conventional therapies. At the present time, there is a growing need to enhance the capability of theranostics procedures where nanomaterials-based sensors may provide for the simultaneous detection of several gene-associated conditions and nanodevices with the ability to monitor real-time drug action. These innovative multifunctional nanocarriers for cancer theranostics may allow the development of diagnostics systems such as colorimetric and immunoassays, and in therapy approaches through gene therapy, drug delivery and tumor targeting systems in cancer.
- Cancer Microenvironment
- Stealth Nanoparticles and Tumour Penetrating Peptides
- Photothermal and Photodynamic therapies
- Ferrofluid and magnetic hyperthermia
- New Nanomaterials
- Imaging and Cancer Theranostics
- Advances in Nanotechnology for cancer treatment
- Translational Nanomedicines
- Cancer Diagnostics
Related Conference of Cancer Nanotheranostics
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia
Miami 2016 Winter Symposium Miami United States of America
2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany
3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India
New and Emerging Trends In Oncology 2016 Hyderabad India
International Conference on Radiation Research Impact on Human Health and Environment Mumbai India
3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore
The Probiotics Congress Asia Kuala Lumpur Malaysia
Molecular Medicine Tri-Con 2016 San Francisco United States of America
ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia
Miami 2016 Winter Symposium Miami United States of America
2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia
Global Engage s Biologics Congress Berlin Germany
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany
3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India
International Conference on Radiation Research Impact on Human Health and Environment Mumbai India
3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore
The Probiotics Congress Asia Kuala Lumpur Malaysia
Molecular Medicine Tri-Con 2016 San Francisco United States of America
ESSO-EYSAC Course on Colorectal Cancer Surgery
Miami 2016 Winter Symposium
2nd AMDI International Biohealth Sciences Conference
Global Engage s Biologics Congress
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach
3rd International Conference on Biotechnology and Bioinformatics
New and Emerging Trends In Oncology
International Conference on Radiation Research Impact on Human Health and Environment
3rd Annual International Conference on Advances in Cancer Medical Research
The Probiotics Congress Asia
Molecular Medicine Tri-Con
Cancer Nanotheranostics Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)

